Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary Cahill
Fatal Thrombocytopaenia Temporally Related to the Administration of Alemtuzumab (MabCampath) for Refractory CLL Despite Early Discontinuation of Therapy
Hematology
Hematology
Related publications
Low-Dose Subcutaneous Alemtuzumab in Refractory Chronic Lymphocytic Leukaemia (CLL): Results of a Prospective, Single-Arm Multicentre Study
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
The First Case of Biological Therapy Discontinuation After a Complete Remission Induced by Maintenance Therapy With Adalimumab for Refractory Ulcerative Colitis
Journal of Clinical Medicine Research
Filgrastim and Alemtuzumab (Campath-1h) for Refractory Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Infusion Reactions Related to Infliximab Therapy Are Not Usually Associated With Drug Discontinuation
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Analysis of Treatment Options for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Rescue Therapy for Refractory ARDS Should Be Offered Early: No
Intensive Care Medicine
Critical Care
Intensive Care Medicine
Fatal Pseudomembranous Colitis Despite Eradication of Clostridium Difficile.
BMJ
Rescue Therapy for Refractory ARDS Should Be Offered Early: Yes
Intensive Care Medicine
Critical Care
Intensive Care Medicine
Hormone Therapy Discontinuation
Menopause
Gynecology
Obstetrics
